Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Fubao Information: Lithium carbonate futures fluctuated downward, Fubao's total social inventory of lithium carbonate is 100,900 tons, an increase of 0.21% from the previous week.

Fubao Information: Lithium carbonate futures fluctuated downward, Fubao's total social inventory of lithium carbonate is 100,900 tons, an increase of 0.21% from the previous week.

金十金十2026/04/09 08:58
Show original
Golden Ten Data Futures, April 9 – According to Fubao Information, today's Fubao electric carbon spot basis index is -840 yuan/ton (unchanged); battery-grade lithium carbonate is quoted at 152,950 yuan/ton (-3,200 yuan/ton); industrial-grade lithium carbonate (comprehensive) is quoted at 151,500 yuan/ton (-3,200 yuan/ton); the average long-term contract price of battery-grade lithium carbonate is 154,000 yuan/ton (-600 yuan/ton); lithium hydroxide index is 144,000 yuan/ton (-3,000 yuan/ton); metallic lithium index is 1,060,000 yuan/ton (unchanged); Fubao brine (lithium sulfate) discount coefficient is reported at 75% (unchanged). As of the week ending April 9, Fubao lithium carbonate production stands at 24,200 tons, an increase of 2.54% week-on-week; Fubao total social inventory of lithium carbonate is 100,900 tons, up 0.21% week-on-week (an increase of 216 from last period), marking a slight increase in inventory for five consecutive weeks.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear

Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

智通财经•2026/11/04 03:53

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51